Who owns INHIBIKASE THERAPEUTICS INC?
- Ticker: IKT
- CUSIP Number: 45719w205
Tip: Access positions for across all investors
Analyze quarterly positions in Inhibikase Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inhibikase Therapeutics stock
Who bought or sold INHIBIKASE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sands Capital Ventures | 13M | $27M | 19% | Dec 2025 |
|
| Soleus Capital Management | 11M | $22M | 72% | Dec 2025 |
|
| Fairmount Funds Management | 8.6M | $18M | 41% | Dec 2025 |
|
| ADAR1 Capital Management | 8.1M | $17M | 54% | Dec 2025 |
|
| Siren | 5.9M | $12M | 100% | Dec 2025 |
|
| Perceptive Advisors | 5.4M | $8.8M | 0% | Sep 2025 |
|
| Commodore Capital | 5.4M | $11M | 0% | Dec 2025 |
|
| Vanguard Group | 4.6M | $9.3M | 39% | Dec 2025 |
|
| Nantahala Capital Management | 3.9M | $8.1M | 79% | Dec 2025 |
|
| Saturn V Capital Management | 3.9M | $7.9M | 100% | Dec 2025 |
|
| BlackRock | 3.3M | $6.8M | 7% | Dec 2025 |
|
| Blackstone Group | 2.6M | $4.3M | 0% | Sep 2025 |
|
| Stonepine Capital Management | 2.3M | $4.8M | 219% | Dec 2025 |
|
| Integral Health Asset Management | 1.8M | $3.6M | 100% | Dec 2025 |
|
| Geode Capital Management | 1.1M | $2.3M | 1% | Dec 2025 |
|
| Exome Asset Management | 600k | $1.2M | 100% | Dec 2025 |
|
| State Street Corporation | 555k | $1.1M | 9% | Dec 2025 |
|
| Seven Fleet Capital Management | 534k | $1.1M | 100% | Dec 2025 |
|
| Northern Trust | 323k | $662k | -14% | Dec 2025 |
|
| William Blair $ Company | 153k | $248k | -3% | Sep 2025 |
|
| Charles Schwab Investment Management | 152k | $312k | 0% | Dec 2025 |
|
| Bank of New York Mellon | 138k | $282k | -1% | Dec 2025 |
|
| Jane Street | 116k | $238k | 100% | Dec 2025 |
|
| FMR | 106k | $171k | -27% | Sep 2025 |
|
| Barclays | 95k | $194k | 11% | Dec 2025 |
|
| UBS Group | 95k | $194k | -31% | Dec 2025 |
|
| Persistent Asset Partners | 93k | $192k | 100% | Dec 2025 |
|
| Goldman Sachs Group | 85k | $175k | 694% | Dec 2025 |
|
| Nuveen | 79k | $161k | 0% | Dec 2025 |
|
| Citadel Advisors | 72k | $116k | 100% | Sep 2025 |
|
| Wells Fargo & Company | 68k | $139k | 48% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 55k | $113k | -32% | Dec 2025 |
|
| Jpmorgan Chase & Co | 50k | $81k | 100% | Sep 2025 |
|
| New York State Common Retirement Fund | 48k | $98k | 0% | Dec 2025 |
|
| Rhumbline Advisers | 47k | $97k | -18% | Dec 2025 |
|
| Invesco | 32k | $66k | -2% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 29k | $59k | 3% | Dec 2025 |
|
| Caxton | 29k | $58k | 74% | Dec 2025 |
|
| Intech Investment Management | 27k | $55k | -16% | Dec 2025 |
|
| Virtu Financial | 23k | $47k | 70% | Dec 2025 |
|
| Susquehanna International | 22k | $44k | -53% | Dec 2025 |
|
| XTX Topco | 20k | $42k | 100% | Dec 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 18k | $36k | 0% | Dec 2025 |
|
| Scientech Research | 16k | $33k | 100% | Dec 2025 |
|
| Ing Investment Management | 13k | $27k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 13k | $26k | -18% | Dec 2025 |
|
| Sanctuary Advisors | 13k | $26k | 100% | Dec 2025 |
|
| Victory Capital Management | 11k | $23k | 100% | Dec 2025 |
|
| ProShare Advisors | 11k | $23k | 7% | Dec 2025 |
|
| Russell Investments | 11k | $22k | 40% | Dec 2025 |
|
| Buckingham Strategic Partners | 11k | $22k | 0% | Dec 2025 |
|
| Hrt Financial | 11k | $21k | 100% | Dec 2025 |
|
| Tower Research Capital | 6.5k | $13k | -8% | Dec 2025 |
|
| Summit Investment Advisors | 6.2k | $13k | 0% | Dec 2025 |
|
| Legal & General Group | 5.5k | $11k | 0% | Dec 2025 |
|
| Pinnacle Wealth Planning Services | 5.4k | $11k | 100% | Dec 2025 |
|
| California State Teachers Retirement System | 3.7k | $7.6k | -2% | Dec 2025 |
|
| Sterling Capital Management | 3.2k | $6.6k | -16% | Dec 2025 |
|
| Amalgamated Bank | 1.9k | $4.0k | -8% | Dec 2025 |
|
| Royal Bank of Canada | 663.00 | $1.0k | -86% | Sep 2025 |
|
| Pnc Financial Services | 101.00 | $206.999500 | 12% | Dec 2025 |
|
| CWM | 73.00 | $0 | 284% | Dec 2025 |
|
| EverSource Wealth Advisors | 4.00 | $8.000000 | 100% | Dec 2025 |
|
| Hanson McClain Advisors | 1.00 | $3.000000 | 100% | Dec 2025 |
|
Who sold out of Inhibikase Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| SRS Capital Advisors | Sep 2025 | 86.00 | $139.001800 |